Novo Nordisk A/s

(FRA) NOVA

Current Price€38.90

Market Cap€129.04B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

Novo Nordisk A/s Financials at a Glance

Market Cap

€129.04B

Revenue (TTM)

€43.90K

Net Income (TTM)

€16.33K

EPS (TTM)

€3.67

P/E Ratio

10.42

Dividend

€1.56

Beta (Volatility)

-0.06 (Low)

Dividend

€1.56

Beta (Volatility)

-0.06 (Low)

Price

€38.90

Volume

670

Open

€38.10

Price

€38.90

Volume

670

Open

€38.10

Previous Close

€38.30

Daily Range

€38.10 - €38.96

52-Week Range

€30.45 - €71.80

Dividend

€1.56

Beta (Volatility)

-0.06 (Low)

Price

€38.90

Volume

670

Open

€38.10

Previous Close

€38.30

Daily Range

€38.10 - €38.96

52-Week Range

€30.45 - €71.80

NOVA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novo Nordisk A/s

Industry

Pharmaceuticals

Sector

Health Care

Employees

68,794

CEO

Maziar Mike Doustdar

Website

www.novonordisk.com

NOVA Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

71%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

9.60%

Dividend Yield

4.08%

Payout Ratio

N/A

Stock Overview

Market Cap

€129.04B

Shares Outstanding

3.37B

Volume

670

Avg. Volume

2.89K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Novo Nordisk A/s Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

€12.96K

+1.2%

Gross Profit

€11.14K

+1.3%

Gross Margin

85.96%

+1.0%

Market Cap

€129.04B

N/A

Market Cap/Employee

€1.55

+0.5%

Employees

68,794

+0.9%

Net Income

€6.50K

+1.7%

EBITDA

€8.47K

+1.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

€2.83K

+0.5%

Accounts Receivable

€11.05K

+1.2%

Inventory

€6.87K

+1.2%

Long Term Debt

€15.95K

+1.2%

Short Term Debt

€3.64K

+1.2%

Return on Assets

23.27%

+0.9%

Return on Invested Capital

50.10%

+0.9%

Free Cash Flow

€1.62K

+0.4%

Operating Cash Flow

€3.13K

+0.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,523.78+0.00%

^DJIDJI

^DJIDJI$50,649.08+0.00%

^IXICNASDAQ

^IXICNASDAQ$26,683.17+0.00%

BTCBitcoin

BTCBitcoin$74,768.00-0.02%

AAPLAAPL

AAPLAAPL$310.82+0.01%

AMZNAMZN

AMZNAMZN$270.07+0.02%

GOOGGOOG

GOOGGOOG$388.40+0.01%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CZRCaesars Entertainment

CZRCaesars Entertainment$29.01+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.47-0.02%

IUSBiShares Trust - iShares Core Universal Usd Bond ETF

IUSBiShares Trust - iShares Core Universal Usd Bond ETF$46.17+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.32+0.00%

SIDUSidus Space

SIDUSidus Space$5.24-0.14%

ATPCAgape Atp

ATPCAgape Atp$6.15+1.16%

IALTBlackrock ETF Trust - iShares Systematic Alternatives Active ETF

IALTBlackrock ETF Trust - iShares Systematic Alternatives Active ETF$28.29+0.00%

Questions About NOVA

What is the current price of Novo Nordisk A/s?

Novo Nordisk A/s is trading at €38.90 per share.

What is the 52-week range for Novo Nordisk A/s?

Over the past 52 weeks, Novo Nordisk A/s has traded between €30.45 and €71.80.

How much debt does Novo Nordisk A/s have?

As of the most recent reporting period, Novo Nordisk A/s reported total debt of €19.59B.

How much cash does Novo Nordisk A/s have on hand?

Novo Nordisk A/s reported €2.83B in cash and cash equivalents in its most recent financial results.

What is Novo Nordisk A/s’s dividend yield?

Novo Nordisk A/s currently has a dividend yield of 4.08%.

Novo Nordisk A/s

Novo Nordisk A/s Financials at a Glance

NOVA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Novo Nordisk A/s

NOVA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Novo Nordisk A/s Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NOVA

What is the current price of Novo Nordisk A/s?

What is the 52-week range for Novo Nordisk A/s?

How much debt does Novo Nordisk A/s have?

How much cash does Novo Nordisk A/s have on hand?

What is Novo Nordisk A/s’s dividend yield?

Premium Investing Services